(1)
Isbagio, H. Use of Anti-Citrullinated Peptide (Anti–CCP) Antibodies in Distinguishing Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. Med J Indones 2004, 13, 227-31.